ATE107656T1 - Verfahren zur herstellung von 14-alpha-hydroxy-4- androsten-3,6,17, trion. - Google Patents

Verfahren zur herstellung von 14-alpha-hydroxy-4- androsten-3,6,17, trion.

Info

Publication number
ATE107656T1
ATE107656T1 AT90102302T AT90102302T ATE107656T1 AT E107656 T1 ATE107656 T1 AT E107656T1 AT 90102302 T AT90102302 T AT 90102302T AT 90102302 T AT90102302 T AT 90102302T AT E107656 T1 ATE107656 T1 AT E107656T1
Authority
AT
Austria
Prior art keywords
alpha
hydroxy
preparation
androsene
trion
Prior art date
Application number
AT90102302T
Other languages
English (en)
Inventor
Masamichi Nakakoshi
Kohji Tamura
Makoto Yoshihama
Nobuo Miyata
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Application granted granted Critical
Publication of ATE107656T1 publication Critical patent/ATE107656T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT90102302T 1989-02-07 1990-02-06 Verfahren zur herstellung von 14-alpha-hydroxy-4- androsten-3,6,17, trion. ATE107656T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1027824A JPH0643439B2 (ja) 1989-02-07 1989-02-07 光による6β,14α‐ジヒドロキシ‐4‐アンドロステン‐3,17‐ジオンの6β位水酸基の酸化方法

Publications (1)

Publication Number Publication Date
ATE107656T1 true ATE107656T1 (de) 1994-07-15

Family

ID=12231698

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90102302T ATE107656T1 (de) 1989-02-07 1990-02-06 Verfahren zur herstellung von 14-alpha-hydroxy-4- androsten-3,6,17, trion.

Country Status (5)

Country Link
US (1) US5098535A (de)
EP (1) EP0382162B1 (de)
JP (1) JPH0643439B2 (de)
AT (1) ATE107656T1 (de)
DE (1) DE69010025T2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06225793A (ja) * 1992-11-27 1994-08-16 Nippon Kayaku Co Ltd 6β,14α−ジヒドロキシ−4−アンドロステン−3,17−ジオンの新規製造法
EP0626388A3 (en) * 1993-05-28 1996-06-19 Nippon Kayaku Kk 14alpha-hydroxy-4-androstene-3,6,17-trione hydrate crystal and process for producing same.
LT2916901T (lt) 2012-11-12 2020-10-12 Hollister Incorporated Pertraukiamas kateterio mazgas
WO2014077886A1 (en) 2012-11-14 2014-05-22 Hollister Incorporated Disposable catheter with selectively degradable inner core
AU2014346748B2 (en) 2013-11-08 2018-05-10 Hollister Incorporated Oleophilic lubricated catheters
AU2014362360B2 (en) 2013-12-12 2020-01-02 Hollister Incorporated Flushable catheters
ES2802950T3 (es) 2013-12-12 2021-01-22 Hollister Inc Catéteres desechables por el inodoro
DK3079749T3 (da) 2013-12-12 2019-12-16 Hollister Inc Udskyllelige katetre
AU2014363933B2 (en) 2013-12-12 2019-10-10 Hollister Incorporated Flushable disintegration catheter
US11185613B2 (en) 2015-06-17 2021-11-30 Hollister Incorporated Selectively water disintegrable materials and catheters made of such materials

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2900382A (en) * 1952-06-28 1959-08-18 Syntex Sa Method of making delta4,6 steroid compounds from delta4 steroid compounds
DE3873200T2 (de) * 1987-02-06 1993-02-25 Snow Brand Milk Prod Co Ltd Neue androst-4-en-3,17-dion-derivate und verfahren zur herstellung.
JPS63192794A (ja) * 1987-02-06 1988-08-10 Snow Brand Milk Prod Co Ltd 14α−ヒドロキシ−4−アンドロステン−3,6,17−トリオン

Also Published As

Publication number Publication date
JPH02207095A (ja) 1990-08-16
DE69010025T2 (de) 1994-12-15
EP0382162A2 (de) 1990-08-16
EP0382162B1 (de) 1994-06-22
US5098535A (en) 1992-03-24
DE69010025D1 (de) 1994-07-28
JPH0643439B2 (ja) 1994-06-08
EP0382162A3 (de) 1991-03-13

Similar Documents

Publication Publication Date Title
DE68919530D1 (de) Verfahren und Zwischenprodukte für die Herstellung von Bis(aminoalkyl)polydiorganosiloxanen.
DE3750749D1 (de) Modifiziertes Dienpolymer und Verfahren zu seiner Herstellung.
DE68919939D1 (de) Verfahren zur Herstellung von Alkenylbernsteinsäureanhydrid-Derivaten.
DE69007885D1 (de) Mit mehreren Oxiden beschichteter Karbidkörper und Verfahren zu seiner Herstellung.
ATE112963T1 (de) Gewebeentzusammensetzung und verfahren.
DE68910145D1 (de) Verfahren zur Herstellung von Azolylmethyl-cyclopentanol-Derivaten.
DE68927703D1 (de) Verfahren zur Herstellung von 2,3-Dimethylbutenen
DE68927949D1 (de) 3,9-Diphosphaspiroundecane und Verfahren zur Herstellung von 3,9-Diphosphaspiroundecanen
ATE107656T1 (de) Verfahren zur herstellung von 14-alpha-hydroxy-4- androsten-3,6,17, trion.
ATE111439T1 (de) Verfahren zur herstellung von levodopa.
DE69007323D1 (de) Verfahren zur Herstellung von sec.-Butylbenzol.
DE69020830D1 (de) Verfahren zur Herstellung von (S)-4-Hydroxymethyl-gamma-lacton.
DE69006911D1 (de) Verfahren zur Herstellung von 3,4-Dichloranilin.
DE68902334D1 (de) Verfahren zur herstellung von automobil-karosserieteilen, insbesondere heckspoiler und nach diesem verfahren hergestellte gegenstaende.
DE68916396D1 (de) Verfahren zur Herstellung eines Carbonsäurealkenylesters.
DE69009682D1 (de) Verfahren zur Herstellung von Cyclohexanolderivaten.
DE68914913D1 (de) Verfahren zur Herstellung von 2-Aminopurin.
DE59106420D1 (de) Verfahren zur Herstellung von Phosphatidylcholinderivaten.
DE69019843D1 (de) Verfahren zur Herstellung von NADH-Oxydase.
DE69013726D1 (de) Verbessertes Verfahren für die Herstellung von o-Carboxypyridyl- und o-Carboxychinolylimidazolinonen.
DE68913394D1 (de) Verfahren zur Herstellung von substituierten Phenoxyethylaminen sowie Zwischenverbindungen.
DE3785537D1 (de) Mikroorganismus und verfahren zur herstellung von oxydationsverbindungen mit diesem mikroorganismus.
DE69007424D1 (de) Verfahren zur Herstellung eines oxidischen Supraleiters.
DE3765855D1 (de) Dimethylphenylsilylmethylpolysilan und verfahren zur herstellung desselben.
DE68913779D1 (de) D-Amidase und Verfahren zur Herstellung von D-alpha-Alanin und/oder L-alpha-Alaninamid.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee